News
09-08-2009, 03:40 AM
A molecular signature that helps account for the aggressive behavior of a variety of cancers such as pancreatic, breast and melanoma may also predict the likelihood of successful treatment with a particular anti-cancer drug. The finding, which could lead to a personalized approach to treatment for a variety of solid tumors that are currently resistant to therapies, will be published September 6 in the advance online edition of Nature Medicine.
More... (http://www.medicalnewstoday.com/articles/163181.php)
More... (http://www.medicalnewstoday.com/articles/163181.php)